nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—DNMT3A—RMTs methylate histone arginines—ARID1B—peripheral nervous system neoplasm	0.0241	0.104	CbGpPWpGaD
Azacitidine—DNMT3A—PRC2 methylates histones and DNA—EED—peripheral nervous system neoplasm	0.0193	0.0837	CbGpPWpGaD
Azacitidine—DNMT3A—PRC2 methylates histones and DNA—SUZ12—peripheral nervous system neoplasm	0.0154	0.0669	CbGpPWpGaD
Azacitidine—DNMT3A—RMTs methylate histone arginines—ARID1A—peripheral nervous system neoplasm	0.0132	0.0573	CbGpPWpGaD
Azacitidine—DNMT1—PRC2 methylates histones and DNA—EED—peripheral nervous system neoplasm	0.013	0.0565	CbGpPWpGaD
Azacitidine—DNMT3A—RMTs methylate histone arginines—SMARCB1—peripheral nervous system neoplasm	0.0127	0.0549	CbGpPWpGaD
Azacitidine—DNMT3A—Epigenetic regulation of gene expression—EED—peripheral nervous system neoplasm	0.0124	0.0537	CbGpPWpGaD
Azacitidine—CDA—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.0118	0.051	CbGpPWpGaD
Azacitidine—DNMT1—PRC2 methylates histones and DNA—SUZ12—peripheral nervous system neoplasm	0.0104	0.0452	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—ARID1B—peripheral nervous system neoplasm	0.0103	0.0447	CbGpPWpGaD
Azacitidine—DNMT3A—Epigenetic regulation of gene expression—SUZ12—peripheral nervous system neoplasm	0.0099	0.0429	CbGpPWpGaD
Azacitidine—DNMT1—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.00971	1	CbGdCrCtD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—SMARCB1—peripheral nervous system neoplasm	0.00948	0.0411	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00932	0.0404	CbGpPWpGaD
Azacitidine—DNMT1—Epigenetic regulation of gene expression—EED—peripheral nervous system neoplasm	0.00836	0.0362	CbGpPWpGaD
Azacitidine—DNMT1—Epigenetic regulation of gene expression—SUZ12—peripheral nervous system neoplasm	0.00669	0.029	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—ARID1A—peripheral nervous system neoplasm	0.00565	0.0245	CbGpPWpGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—SMARCB1—peripheral nervous system neoplasm	0.00541	0.0235	CbGpPWpGaD
Azacitidine—Adenosine triphosphate—ALK—peripheral nervous system neoplasm	0.00425	0.46	CrCbGaD
Azacitidine—Adenosine triphosphate—AKT1—peripheral nervous system neoplasm	0.00332	0.359	CrCbGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—ERBB2—peripheral nervous system neoplasm	0.00328	0.0142	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.00307	0.0133	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—MET—peripheral nervous system neoplasm	0.00292	0.0126	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—MYC—peripheral nervous system neoplasm	0.00232	0.0101	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00228	0.0099	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CDKN2A—peripheral nervous system neoplasm	0.00223	0.00967	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—EED—peripheral nervous system neoplasm	0.00207	0.00897	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.00165	0.00717	CbGpPWpGaD
Azacitidine—CDA—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00154	0.00668	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—EED—peripheral nervous system neoplasm	0.0014	0.00606	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.00121	0.00525	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.00112	0.00484	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GNS—peripheral nervous system neoplasm	0.00111	0.00483	CbGpPWpGaD
Azacitidine—Gemcitabine—ABCB1—peripheral nervous system neoplasm	0.00109	0.118	CrCbGaD
Azacitidine—CDA—Metabolism—NME1—peripheral nervous system neoplasm	0.00107	0.00463	CbGpPWpGaD
Azacitidine—CDA—Metabolism—COX2—peripheral nervous system neoplasm	0.00103	0.00446	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000995	0.00431	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ENO2—peripheral nervous system neoplasm	0.000675	0.00293	CbGpPWpGaD
Azacitidine—Adenosine triphosphate—ABCB1—peripheral nervous system neoplasm	0.00058	0.0628	CrCbGaD
Azacitidine—CDA—Metabolism—BCHE—peripheral nervous system neoplasm	0.000571	0.00247	CbGpPWpGaD
Azacitidine—CDA—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000544	0.00236	CbGpPWpGaD
Azacitidine—CDA—Metabolism—TH—peripheral nervous system neoplasm	0.000537	0.00233	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GNAS—peripheral nervous system neoplasm	0.000438	0.0019	CbGpPWpGaD
Azacitidine—CDA—Metabolism—ABCB1—peripheral nervous system neoplasm	0.00043	0.00186	CbGpPWpGaD
Azacitidine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000322	0.000429	CcSEcCtD
Azacitidine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000322	0.000429	CcSEcCtD
Azacitidine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000322	0.000429	CcSEcCtD
Azacitidine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000321	0.000428	CcSEcCtD
Azacitidine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000321	0.000427	CcSEcCtD
Azacitidine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000425	CcSEcCtD
Azacitidine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000319	0.000425	CcSEcCtD
Azacitidine—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000424	CcSEcCtD
Azacitidine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000424	CcSEcCtD
Azacitidine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000422	CcSEcCtD
Azacitidine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000315	0.000419	CcSEcCtD
Azacitidine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000313	0.000417	CcSEcCtD
Azacitidine—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000417	CcSEcCtD
Azacitidine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000312	0.000416	CcSEcCtD
Azacitidine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.000415	CcSEcCtD
Azacitidine—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000415	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000311	0.000414	CcSEcCtD
Azacitidine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000412	CcSEcCtD
Azacitidine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000308	0.000411	CcSEcCtD
Azacitidine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000308	0.00041	CcSEcCtD
Azacitidine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000409	CcSEcCtD
Azacitidine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000405	CcSEcCtD
Azacitidine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000405	CcSEcCtD
Azacitidine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000303	0.000404	CcSEcCtD
Azacitidine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000404	CcSEcCtD
Azacitidine—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000403	CcSEcCtD
Azacitidine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000401	CcSEcCtD
Azacitidine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.0003	0.0004	CcSEcCtD
Azacitidine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.000399	CcSEcCtD
Azacitidine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000297	0.000396	CcSEcCtD
Azacitidine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000392	CcSEcCtD
Azacitidine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000294	0.000392	CcSEcCtD
Azacitidine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000292	0.000389	CcSEcCtD
Azacitidine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000389	CcSEcCtD
Azacitidine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00029	0.000387	CcSEcCtD
Azacitidine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00029	0.000387	CcSEcCtD
Azacitidine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00029	0.000386	CcSEcCtD
Azacitidine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000386	CcSEcCtD
Azacitidine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000289	0.000385	CcSEcCtD
Azacitidine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000287	0.000383	CcSEcCtD
Azacitidine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000287	0.000382	CcSEcCtD
Azacitidine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000381	CcSEcCtD
Azacitidine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000285	0.00038	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000285	0.00038	CcSEcCtD
Azacitidine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000285	0.000379	CcSEcCtD
Azacitidine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000284	0.000379	CcSEcCtD
Azacitidine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000377	CcSEcCtD
Azacitidine—Pain—Etoposide—peripheral nervous system neoplasm	0.000282	0.000376	CcSEcCtD
Azacitidine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000282	0.000376	CcSEcCtD
Azacitidine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000376	CcSEcCtD
Azacitidine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000375	CcSEcCtD
Azacitidine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000375	CcSEcCtD
Azacitidine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000373	CcSEcCtD
Azacitidine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00028	0.000373	CcSEcCtD
Azacitidine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000279	0.000371	CcSEcCtD
Azacitidine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000369	CcSEcCtD
Azacitidine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000366	CcSEcCtD
Azacitidine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000365	CcSEcCtD
Azacitidine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000363	CcSEcCtD
Azacitidine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000363	CcSEcCtD
Azacitidine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000272	0.000362	CcSEcCtD
Azacitidine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000271	0.000361	CcSEcCtD
Azacitidine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000361	CcSEcCtD
Azacitidine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.00036	CcSEcCtD
Azacitidine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00027	0.00036	CcSEcCtD
Azacitidine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000269	0.000359	CcSEcCtD
Azacitidine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000269	0.000358	CcSEcCtD
Azacitidine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000358	CcSEcCtD
Azacitidine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000358	CcSEcCtD
Azacitidine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.000355	CcSEcCtD
Azacitidine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000266	0.000355	CcSEcCtD
Azacitidine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000265	0.000354	CcSEcCtD
Azacitidine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000265	0.000353	CcSEcCtD
Azacitidine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000352	CcSEcCtD
Azacitidine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000262	0.000349	CcSEcCtD
Azacitidine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000349	CcSEcCtD
Azacitidine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000349	CcSEcCtD
Azacitidine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000348	CcSEcCtD
Azacitidine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000261	0.000348	CcSEcCtD
Azacitidine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000261	0.000348	CcSEcCtD
Azacitidine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000348	CcSEcCtD
Azacitidine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000347	CcSEcCtD
Azacitidine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000345	CcSEcCtD
Azacitidine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000259	0.000345	CcSEcCtD
Azacitidine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000258	0.000344	CcSEcCtD
Azacitidine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000344	CcSEcCtD
Azacitidine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000343	CcSEcCtD
Azacitidine—Rash—Vincristine—peripheral nervous system neoplasm	0.000257	0.000342	CcSEcCtD
Azacitidine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000257	0.000342	CcSEcCtD
Azacitidine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000342	CcSEcCtD
Azacitidine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000341	CcSEcCtD
Azacitidine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000341	CcSEcCtD
Azacitidine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000255	0.00034	CcSEcCtD
Azacitidine—Headache—Vincristine—peripheral nervous system neoplasm	0.000255	0.00034	CcSEcCtD
Azacitidine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000338	CcSEcCtD
Azacitidine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000337	CcSEcCtD
Azacitidine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000336	CcSEcCtD
Azacitidine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000251	0.000335	CcSEcCtD
Azacitidine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000334	CcSEcCtD
Azacitidine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000246	0.000328	CcSEcCtD
Azacitidine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000324	CcSEcCtD
Azacitidine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000243	0.000324	CcSEcCtD
Azacitidine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000323	CcSEcCtD
Azacitidine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000242	0.000322	CcSEcCtD
Azacitidine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000322	CcSEcCtD
Azacitidine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000322	CcSEcCtD
Azacitidine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000321	CcSEcCtD
Azacitidine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000319	CcSEcCtD
Azacitidine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000319	CcSEcCtD
Azacitidine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000317	CcSEcCtD
Azacitidine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000316	CcSEcCtD
Azacitidine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000237	0.000316	CcSEcCtD
Azacitidine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000315	CcSEcCtD
Azacitidine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000315	CcSEcCtD
Azacitidine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000315	CcSEcCtD
Azacitidine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000313	CcSEcCtD
Azacitidine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000313	CcSEcCtD
Azacitidine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000311	CcSEcCtD
Azacitidine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000233	0.000311	CcSEcCtD
Azacitidine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000307	CcSEcCtD
Azacitidine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000229	0.000305	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—MYC—peripheral nervous system neoplasm	0.000229	0.000991	CbGpPWpGaD
Azacitidine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000304	CcSEcCtD
Azacitidine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000227	0.000303	CcSEcCtD
Azacitidine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000227	0.000302	CcSEcCtD
Azacitidine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000302	CcSEcCtD
Azacitidine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000302	CcSEcCtD
Azacitidine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000226	0.000301	CcSEcCtD
Azacitidine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.0003	CcSEcCtD
Azacitidine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000298	CcSEcCtD
Azacitidine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000292	CcSEcCtD
Azacitidine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000291	CcSEcCtD
Azacitidine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000218	0.000291	CcSEcCtD
Azacitidine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000218	0.00029	CcSEcCtD
Azacitidine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.00029	CcSEcCtD
Azacitidine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000289	CcSEcCtD
Azacitidine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000288	CcSEcCtD
Azacitidine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000214	0.000285	CcSEcCtD
Azacitidine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000284	CcSEcCtD
Azacitidine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000281	CcSEcCtD
Azacitidine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00021	0.00028	CcSEcCtD
Azacitidine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00021	0.00028	CcSEcCtD
Azacitidine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000279	CcSEcCtD
Azacitidine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000279	CcSEcCtD
Azacitidine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000279	CcSEcCtD
Azacitidine—Rash—Etoposide—peripheral nervous system neoplasm	0.000208	0.000277	CcSEcCtD
Azacitidine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000208	0.000277	CcSEcCtD
Azacitidine—Headache—Etoposide—peripheral nervous system neoplasm	0.000207	0.000275	CcSEcCtD
Azacitidine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000272	CcSEcCtD
Azacitidine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000271	CcSEcCtD
Azacitidine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000203	0.00027	CcSEcCtD
Azacitidine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.00027	CcSEcCtD
Azacitidine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000269	CcSEcCtD
Azacitidine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000265	CcSEcCtD
Azacitidine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000264	CcSEcCtD
Azacitidine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000262	CcSEcCtD
Azacitidine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000196	0.000261	CcSEcCtD
Azacitidine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000261	CcSEcCtD
Azacitidine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000259	CcSEcCtD
Azacitidine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000258	CcSEcCtD
Azacitidine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000257	CcSEcCtD
Azacitidine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000257	CcSEcCtD
Azacitidine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000257	CcSEcCtD
Azacitidine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000256	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000255	CcSEcCtD
Azacitidine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000254	CcSEcCtD
Azacitidine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000252	CcSEcCtD
Azacitidine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000251	CcSEcCtD
Azacitidine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.00025	CcSEcCtD
Azacitidine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000249	CcSEcCtD
Azacitidine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000247	CcSEcCtD
Azacitidine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000247	CcSEcCtD
Azacitidine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000246	CcSEcCtD
Azacitidine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000245	CcSEcCtD
Azacitidine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000244	CcSEcCtD
Azacitidine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000243	CcSEcCtD
Azacitidine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000242	CcSEcCtD
Azacitidine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000242	CcSEcCtD
Azacitidine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000241	CcSEcCtD
Azacitidine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000241	CcSEcCtD
Azacitidine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000241	CcSEcCtD
Azacitidine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000239	CcSEcCtD
Azacitidine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000238	CcSEcCtD
Azacitidine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000238	CcSEcCtD
Azacitidine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000238	CcSEcCtD
Azacitidine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000238	CcSEcCtD
Azacitidine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000237	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000236	CcSEcCtD
Azacitidine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000235	CcSEcCtD
Azacitidine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000235	CcSEcCtD
Azacitidine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00023	CcSEcCtD
Azacitidine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.00023	CcSEcCtD
Azacitidine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000228	CcSEcCtD
Azacitidine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000228	CcSEcCtD
Azacitidine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000227	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000225	CcSEcCtD
Azacitidine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000224	CcSEcCtD
Azacitidine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000224	CcSEcCtD
Azacitidine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000223	CcSEcCtD
Azacitidine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000223	CcSEcCtD
Azacitidine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000223	CcSEcCtD
Azacitidine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000222	CcSEcCtD
Azacitidine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000221	CcSEcCtD
Azacitidine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00022	CcSEcCtD
Azacitidine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000217	CcSEcCtD
Azacitidine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000217	CcSEcCtD
Azacitidine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000214	CcSEcCtD
Azacitidine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000213	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000213	CcSEcCtD
Azacitidine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000213	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—AKT1—peripheral nervous system neoplasm	0.000159	0.000688	CbGpPWpGaD
Azacitidine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000211	CcSEcCtD
Azacitidine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000211	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000208	CcSEcCtD
Azacitidine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000206	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—MYC—peripheral nervous system neoplasm	0.000154	0.00067	CbGpPWpGaD
Azacitidine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000203	CcSEcCtD
Azacitidine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000203	CcSEcCtD
Azacitidine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000202	CcSEcCtD
Azacitidine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000201	CcSEcCtD
Azacitidine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000198	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000197	CcSEcCtD
Azacitidine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000197	CcSEcCtD
Azacitidine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000196	CcSEcCtD
Azacitidine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000195	CcSEcCtD
Azacitidine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000195	CcSEcCtD
Azacitidine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000195	CcSEcCtD
Azacitidine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000195	CcSEcCtD
Azacitidine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000188	CcSEcCtD
Azacitidine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000187	CcSEcCtD
Azacitidine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000182	CcSEcCtD
Azacitidine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000181	CcSEcCtD
Azacitidine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.00018	CcSEcCtD
Azacitidine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.00018	CcSEcCtD
Azacitidine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000177	CcSEcCtD
Azacitidine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000174	CcSEcCtD
Azacitidine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000169	CcSEcCtD
Azacitidine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000168	CcSEcCtD
Azacitidine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000164	CcSEcCtD
Azacitidine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000163	CcSEcCtD
Azacitidine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000161	CcSEcCtD
Azacitidine—CDA—Metabolism—AKT1—peripheral nervous system neoplasm	0.000118	0.000513	CbGpPWpGaD
Azacitidine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000157	CcSEcCtD
Azacitidine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000156	CcSEcCtD
Azacitidine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000155	CcSEcCtD
Azacitidine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000155	CcSEcCtD
Azacitidine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000154	CcSEcCtD
Azacitidine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000151	CcSEcCtD
Azacitidine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000146	CcSEcCtD
Azacitidine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000145	CcSEcCtD
Azacitidine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000144	CcSEcCtD
Azacitidine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000144	CcSEcCtD
Azacitidine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000143	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—AKT1—peripheral nervous system neoplasm	0.000107	0.000464	CbGpPWpGaD
Azacitidine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000135	CcSEcCtD
